Antibody Testing Market

Market Study on Antibody Testing: Serological Test Kits to Remain Highly Popular

Antibody Testing Market Segmented By Serological Test Kit, Immunoglobulin Kits, Lateral Flow Assay Kits, Chemicals and Reagents, Consumables Product with Pregnancy, Cardiovascular Disease, Autoimmune Disease, Infectious Disease, Oncology, Endocrine Disease, Diabetes Indication

  • November-2021
  • PMRREP31930
  • 225 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Outlook

        4.1.3. Global Biotech and Biopharma Industry Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Prevalence of Various Diseases

        4.2.2. Historic Growth of Key Manufacturers

        4.2.3. Adoption of Antibody Testing Kits

        4.2.4. Product in Pipeline

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 financial analysis

    5.4. COVID19 and Impact Analysis

        5.4.1. Revenue By Product

        5.4.2. Revenue By Indication

        5.4.3. Revenue By End User

        5.4.4. Revenue By Country

    5.5. 2020 Market Scenario

6. Key Success Factors

    6.1. Recent Development/ Approvals

    6.2. Strategic Promotional Strategies

    6.3. Supply Chain Analysis

    6.4. Porter’s Five Forces Analysis

    6.5. Regulatory Dynamics

7. Global Chromatography Resins Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (In Value or Size in US$ Mn) Trend By Product, 2016-2020

    8.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By Product, 2021-2031

        8.3.1. Serological Testing Kits

        8.3.2. Immunoglobulin Kits

        8.3.3. Lateral Flow Assay Kits

        8.3.4. Chemical and Reagents

        8.3.5. Consumables

    8.4. Market Attractiveness Analysis By Product

9. Global Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031, By Indication

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (In Value or Size in US$ Mn) Trend By Indication, 2016-2020

    9.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By Indication, 2021-2031

        9.3.1. Pregnancy

        9.3.2. Cardiovascular Diseases

        9.3.3. Autoimmune Diseases

        9.3.4. Infectious Diseases

        9.3.5. Oncology

        9.3.6. Endocrine Diseases

        9.3.7. Diabetes

        9.3.8. Others

    9.4. Market Attractiveness Analysis By Indication

10. Global Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (In Value or Size in US$ Mn) Trend By End User, 2016-2020

    10.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By End User , 2021-2031

        10.3.1. Hospitals

        10.3.2. Academic and Research Institutes

        10.3.3. Diagnostic Laboratories

        10.3.4. Biopharmaceutical Companies

        10.3.5. Homecare settings

    10.4. Market Attractiveness Analysis By End User

11. Global Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    11.1. Introduction

    11.2. Historical Market Size (In Value or Size in US$ Mn) Analysis By Region, 2016 - 2020

    11.3. Current Market Size (In Value or Size in US$ Mn) Analysis and Forecast By Region, 2021 - 2031

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. South Asia

        11.3.5. East Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    12.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2021-2031

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    13.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2021-2031

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Rest of Latin America

        13.3.2. By Product

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    14.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast By Market Taxonomy 2021-2031

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. Russia

            14.3.1.7. BENELUX

            14.3.1.8. Rest of Europe

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    15.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy 2021-2031

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    16.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy 2021-2031

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    17.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy 2021-2031

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Antibody Testing Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    18.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis By Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. South Africa

            18.3.1.3. Rest of Middle East and Africa

        18.3.2. By Product

        18.3.3. By Indication

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key Countries Antibody Testing Market Analysis 2021 & 2031

    19.1. U.S. Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.1.1. By Product

        19.1.2. By Indication

        19.1.3. By End User

    19.2. Canada Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.2.1. By Product

        19.2.2. By Indication

        19.2.3. By End User

    19.3. Brazil Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.3.1. By Product

        19.3.2. By Indication

        19.3.3. By End User

    19.4. Mexico Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.4.1. By Product

        19.4.2. By Indication

        19.4.3. By End User

    19.5. U.K. Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.5.1. By Product

        19.5.2. By Indication

        19.5.3. By End User

    19.6. Germany Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.6.1. By Product

        19.6.2. By Indication

        19.6.3. By End User

    19.7. France Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.7.1. By Product

        19.7.2. By Indication

        19.7.3. By End User

    19.8. Italy Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.8.1. By Product

        19.8.2. By Indication

        19.8.3. By End User

    19.9. Spain Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.9.1. By Product

        19.9.2. By Indication

        19.9.3. By End User

    19.10. Russia Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.10.1. By Product

        19.10.2. By Indication

        19.10.3. By End User

    19.11. BENELUX Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.11.1. By Product

        19.11.2. By Indication

        19.11.3. By End User

    19.12. India Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.12.1. By Product

        19.12.2. By Indication

        19.12.3. By End User

    19.13. Thailand Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.13.1. By Product

        19.13.2. By Indication

        19.13.3. By End User

    19.14. Indonesia Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.14.1. By Product

        19.14.2. By Indication

        19.14.3. By End User

    19.15. Malaysia Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.15.1. By Product

        19.15.2. By Indication

        19.15.3. By End User

    19.16. China Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.16.1. By Product

        19.16.2. By Indication

        19.16.3. By End User

    19.17. South Korea Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.17.1. By Product

        19.17.2. By Indication

        19.17.3. By End User

    19.18. Japan Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.18.1. By Product

        19.18.2. By Indication

        19.18.3. By End User

    19.19. Australia Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.19.1. By Product

        19.19.2. By Indication

        19.19.3. By End User

    19.20. New Zealand Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.20.1. By Product

        19.20.2. By Indication

        19.20.3. By End User

    19.21. GCC Countries Antibody Testing Market Value (US$) Analysis, 2021 & 2031

        19.21.1. By Product

        19.21.2. By Indication

        19.21.3. By End User

    19.22. South Africa Antibody Testing Market Value (US$) and Analysis, 2021 & 2031

        19.22.1. By Product

        19.22.2. By Indication

        19.22.3. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

    20.4. Market Presence Analysis

            20.4.1.1. Regional footprint of Players

            20.4.1.2. Method foot print by Players

            20.4.1.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Thermo Fisher Scientific

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Profitability by Market Segments (Product/End User/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Strategy Overview

                21.3.1.5.1. Marketing Strategy

                21.3.1.5.2. Product Strategy

                21.3.1.5.3. End User Strategy

        21.3.2. Abbott Laboratories

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Profitability by Market Segments (Product/End User/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Strategy Overview

                21.3.2.5.1. Marketing Strategy

                21.3.2.5.2. Product Strategy

                21.3.2.5.3. End User Strategy

        21.3.3. Bio-Rad Laboratories, Inc.

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Profitability by Market Segments (Product/End User/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Strategy Overview

                21.3.3.5.1. Marketing Strategy

                21.3.3.5.2. Product Strategy

                21.3.3.5.3. End User Strategy

        21.3.4. Beckton, Dickinson and Company

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Profitability by Market Segments (Product/End User/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Strategy Overview

                21.3.4.5.1. Marketing Strategy

                21.3.4.5.2. Product Strategy

                21.3.4.5.3. End User Strategy

        21.3.5. F. Hoffmann-La Roche

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Profitability by Market Segments (Product/End User/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Strategy Overview

                21.3.5.5.1. Marketing Strategy

                21.3.5.5.2. Product Strategy

                21.3.5.5.3. End User Strategy

        21.3.6. Agilent Technologies

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Profitability by Market Segments (Product/End User/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Strategy Overview

                21.3.6.5.1. Marketing Strategy

                21.3.6.5.2. Product Strategy

                21.3.6.5.3. End User Strategy

        21.3.7. DiaSorin

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Profitability by Market Segments (Product/End User/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Strategy Overview

                21.3.7.5.1. Marketing Strategy

                21.3.7.5.2. Product Strategy

                21.3.7.5.3. End User Strategy

        21.3.8. Zeus Scientific

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Profitability by Market Segments (Product/End User/Region)

            21.3.8.4. Sales Footprint

            21.3.8.5. Strategy Overview

                21.3.8.5.1. Marketing Strategy

                21.3.8.5.2. Product Strategy

                21.3.8.5.3. End User Strategy

        21.3.9. Abcam PLC

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Profitability by Market Segments (Product/End User/Region)

            21.3.9.4. Sales Footprint

            21.3.9.5. Strategy Overview

                21.3.9.5.1. Marketing Strategy

                21.3.9.5.2. Product Strategy

                21.3.9.5.3. End User Strategy

        21.3.10. Trinity Biotech

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Profitability by Market Segments (Product/End User/Region)

            21.3.10.4. Sales Footprint

            21.3.10.5. Strategy Overview

                21.3.10.5.1. Marketing Strategy

                21.3.10.5.2. Product Strategy

                21.3.10.5.3. End User Strategy

        21.3.11. Werfen (Biokit)

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Profitability by Market Segments (Product/End User/Region)

            21.3.11.4. Sales Footprint

            21.3.11.5. Strategy Overview

                21.3.11.5.1. Marketing Strategy

                21.3.11.5.2. Product Strategy

                21.3.11.5.3. End User Strategy

        21.3.12. Promega

            21.3.12.1. Overview

            21.3.12.2. Product Portfolio

            21.3.12.3. Profitability by Market Segments (Product/End User/Region)

            21.3.12.4. Sales Footprint

            21.3.12.5. Strategy Overview

                21.3.12.5.1. Marketing Strategy

                21.3.12.5.2. Product Strategy

                21.3.12.5.3. End User Strategy

        21.3.13. BioLegend

            21.3.13.1. Overview

            21.3.13.2. Product Portfolio

            21.3.13.3. Profitability by Market Segments (Product/End User/Region)

            21.3.13.4. Sales Footprint

            21.3.13.5. Strategy Overview

                21.3.13.5.1. Marketing Strategy

                21.3.13.5.2. Product Strategy

                21.3.13.5.3. End User Strategy

        21.3.14. Meridian Bioscience

            21.3.14.1. Overview

            21.3.14.2. Product Portfolio

            21.3.14.3. Profitability by Market Segments (Product/End User/Region)

            21.3.14.4. Sales Footprint

            21.3.14.5. Strategy Overview

                21.3.14.5.1. Marketing Strategy

                21.3.14.5.2. Product Strategy

                21.3.14.5.3. End User Strategy

        21.3.15. Bio-Techne (R&D Systems)

            21.3.15.1. Overview

            21.3.15.2. Product Portfolio

            21.3.15.3. Profitability by Market Segments (Product/End User/Region)

            21.3.15.4. Sales Footprint

            21.3.15.5. Strategy Overview

                21.3.15.5.1. Marketing Strategy

                21.3.15.5.2. Product Strategy

                21.3.15.5.3. End User Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: COVID-19 Region-wise Analysis

Table 02: Pipeline Assessment of Antibody-Based Tests

Table 03: Global Antibody Testing Market Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031, by Product

Table 04: Global Antibody Testing Market value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, by Indication

Table 05: Global Antibody Testing Market value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, by End User

Table 06: Global Antibody Testing Market value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, by Region

Table 07: North America Antibody Testing Market value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 08: North America Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 09: North America Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 10: North America Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Table 11: Latin America Antibody Testing Market value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 12: Latin America Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 13: Latin America Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 14: Latin America Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Table 15: Europe Antibody Testing Market value(US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 16: Europe Antibody Testing Market value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 17: Europe Antibody Testing Market value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 18: Europe Antibody Testing Market value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Table 19: East Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 20: East Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 21: East Asia Antibody Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 22: East Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Table 23: South Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 24: South Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 25: South Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 26: South Asia Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Table 27: Oceania Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 28: Oceania Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 29: Oceania Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 30: Oceania Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Table 31: MEA Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Table 32: MEA Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product

Table 33: MEA Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 34: MEA Antibody Testing Market (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End Users

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Antibody Testing Market Share by, Product (2021)

Figure 02: Antibody Testing Market Share by, Indication (2021)

Figure 03: Antibody Testing Market Share by, End User (2021)

Figure 04: Antibody Testing Market Share by, Region (2021)

Figure 05: Historical Market Value (US$ Mn) Analysis, 2016-2020

Figure 06: Y-o-Y Growth Trend Analysis

Figure 07: Absolute $ Opportunity Analysis

Figure 08: Global Antibody Testing Market Share Analysis (%) by Product, 2021& 2031

Figure 09: Global Antibody Testing Market Y-o-Y Growth (%) by Product, 2021–2031

Figure 10: Global Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 11: Global Antibody Testing Market Share Analysis (%) by Indication, 2021 & 2031

Figure 12: Global Antibody Testing Market Y-o-Y Growth (%) by Indication, 2021–2031

Figure 13: Global Antibody Testing Market Attractiveness Analysis by End User, 2021–2031

Figure 14: Global Antibody Testing Market Share Analysis (%) by End User, 2021 & 2031

Figure 15: Global Antibody Testing Market Y-o-Y Growth (%) by End User, 2021–2031

Figure 16: Global Antibody Testing Market Attractiveness Analysis by End User, 2021–2031

Figure 17: Global Antibody Testing Market Share Analysis (%) by Region, 2021 & 2031

Figure 18: Global Antibody Testing Market Y-o-Y Growth (%) by Region, 2021–2031

Figure 19: Global Antibody Testing Market Attractiveness Analysis by Region, 2021–2031

Figure 20: North America Antibody Testing Market

Figure 21: North America Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 22: North America Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 23: North America Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 24: North America Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 25: North America Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 26: Latin America Antibody Testing Market

Figure 27: Latin America Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 28: Latin America Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 29: Latin America Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 30: Latin America Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 31: Latin America Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 32: Europe Antibody Testing Market

Figure 33: Europe Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 34: Europe Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 35: Europe Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 36: Europe Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 37: Europe Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 38: East Asia Antibody Testing Market

Figure 39: East Asia Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 40: East Asia Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 41: East Asia Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 42: East Asia Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 43: East Asia Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 44: South Asia Antibody Testing Market

Figure 45: South Asia Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 46: South Asia Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 47: South Asia Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 48: South Asia Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 49: South Asia Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 50: Oceania Antibody Testing Market

Figure 51: Oceania Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 52: Oceania Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 53: Oceania Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 54: Oceania Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 55: Oceania Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 56: MEA Antibody Testing Market

Figure 57: MEA Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2020–2031

Figure 58: MEA Antibody Testing Market Attractiveness Analysis by Product , 2021–2031

Figure 59: MEA Antibody Testing Market Attractiveness Analysis by Indication, 2021–2031

Figure 60: MEA Antibody Testing Market Attractiveness Analysis by End User , 2021–2031

Figure 61: MEA Antibody Testing Market Attractiveness Analysis by Country, 2021–2031

Figure 62: U.S. Antibody Testing Market Share Analysis (%), by Product , 2021

Figure 63: U.S. Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 64: U.S. Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 65: Canada Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 66: Canada Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 67: Canada Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 68: Brazil Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 69: Brazil Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 70: Brazil Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 71: Mexico Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 72: Mexico Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 73: Mexico Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 74: Argentina Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 75: Argentina Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 76: Argentina Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 77: Rest of Latin America Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 78: Rest of Latin America Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 79: Rest of Latin America Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 80: U.K. Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 81: U.K. Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 82: U.K. Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 83: Germany Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 84: Germany Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 85: Germany Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 86: France Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 87: France Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 88: France Antibody Testing Market Share Analysis %), by End User, 2021

Figure 89: Italy Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 90: Italy Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 91: Italy Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 92: Spain Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 93: Spain Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 94: Spain Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 95: Russia Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 96: Russia Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 97: Russia Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 98: Rest of Europe Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 99: Rest of Europe Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 100: Rest of Europe Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 101: China Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 102: China Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 103: China Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 104: Japan Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 105: Japan Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 106: Japan Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 107: South Korea Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 108: South Korea Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 109: South Korea Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 110: India Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 111: India Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 112: India Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 113: Malaysia Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 114: Malaysia Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 115: Malaysia Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 116: Indonesia Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 117: Indonesia Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 118: Indonesia Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 119: Thailand Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 119: Rest of South Asia Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 120: Thailand Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 120: Rest of South Asia Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 121: Thailand Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 121: Rest of South Asia Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 122: Australia Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 123: Australia Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 124: Australia Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 125: New Zealand Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 126: New Zealand Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 127: New Zealand Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 128: GCC Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 129: GCC Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 130: GCC Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 131: Turkey Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 132: Turkey Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 133: Turkey Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 134: South Africa Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 135: South Africa Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 136: South Africa Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 137: North Africa Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 138: North Africa Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 139: North Africa Antibody Testing Market Share Analysis (%), by End User, 2021

Figure 140: Rest of MEA Antibody Testing Market Share Analysis (%), by Product, 2021

Figure 141: Rest of MEA Antibody Testing Market Share Analysis (%), By, Indication, 2021 & 2031

Figure 142: Rest of MEA Antibody Testing Market Share Analysis (%), by End User, 2021

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Antibody Testing Market - Scope of Report

The latest publication by Persistence Market Research on the global antibody testing market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for antibody testing products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the antibody testing market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the antibody testing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the antibody testing market offers information divided into four important segments – product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • Serological Test Kits
    • Serological Assay Test Kits
    • Serological Rapid Assay Kits
  • Immunoglobulin Kits
    • Immunoglobulin Assay Test Kits
    • Immunoglobulin Rapid Assay Kits
  • Lateral Flow Assay Kits
    • Lateral Flow Assay Test Kits
    • Lateral Flow Rapid Assay Kits
  • Chemical and Reagents
  • Consumables

Indication

  • Pregnancy
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Infectious Diseases
  • Oncology
  • Endocrine Diseases
  • Diabetes
  • Others

End User

  • Hospitals
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Biopharmaceutical Companies
  • Homecare Settings

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for antibody testing over the coming years?
  • How will changing trends impact the market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the antibody testing market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibody testing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the antibody testing market more accurate and reliable.

Recommendations

Propylene Glycol Ether Market

The global propylene glycol ether market is estimated to have been valued at US$ 1,604.1 Mn by 2017 end and is expected to reach US$ 2,088.4 Mn by the end of 2026 while expanding at a CAGR of 3.0% over the forecast period. .

Methyl Ethyl Ketone Market

The expected value of the global MEK market is expected to be US$ 800.2 Mn in 2018 and the market is estimated to reach US$ 1,055.6 Mn by the end of forecast period..

Isoparaffin Solvents Market

The incremental $ opportunity created by the market during the forecast period is pegged at nearly US$ 51.9 Mn. The isoparaffin solvents market is expected to expand at a CAGR of 3.7% during the forecast period..

2 Ethylhexanol Market

South Asia and Pacific and MEA, are estimated to witness a steady growth spurred by rapid economic development. These regions are estimated to hold a prominent share in the 2-ethylhexanol market during the forecast period..

Our Clients

Our Clients